Point-of-Care Opioid Testing: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033
A recent market study published by FMI on Point-of-Care Opioid Testing offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
By Product:
- Strips
- Cassettes
- Drug Test Dip Cards
By Modality:
- Single-panel Drug Test Kits
- Multi-panel Drug Test Kits
By Sample:
- Saliva
- Blood
- Urine
- Others
By End User:
- Hospitals
- Diagnostics Laboratories
- Forensic Laboratories
- Home Care Settings
- Others
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East & Africa
Report Chapters
Executive Summary
The executive summary of the Point-of-Care Opioid Testing includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Point-of-Care Opioid Testing.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the Point-of-Care Opioid Testing in this chapter, which will help to understand basic information about Point-of-Care Opioid Testing. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Point-of-Care Opioid Testing report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Product processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global Point-of-Care Opioid Testing Demand Analysis 2018-2022 and Forecast, 2023-2033
The chapter include historical market value (XX) analysis (2018-2022) and current and future market value (USD 725.1 million) and volume (4.9%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global Point-of-Care Opioid Testing - Pricing Analysis
Based on By Product, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033, By Product
Based on By Product, Point-of-Care Opioid Testing is segmented into Strips, Cassettes, Drug Test Dip Cards. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Product.
Chapter 06 - Global Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033, By Modality
Based on By Modality, Point-of-Care Opioid Testing is segmented into Single-panel Drug Test Kits, Multi-panel Drug Test Kits. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Modality.
Chapter 07 - Global Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033, By Sample
Based on By Sample, Point-of-Care Opioid Testing is segmented into Saliva, Blood, Urine, Others. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Sample.
Chapter 08 - Global Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033, By End User
Based on By End User, Point-of-Care Opioid Testing is segmented into Hospitals, Diagnostics Laboratories, Forensic Laboratories, Home Care Settings, Others. This section also offers market attractiveness analysis based on By End User. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End User.
Chapter 09 - Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033, By Region
Based on By Region, Point-of-Care Opioid Testing is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 10 - North America Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the Point-of-Care Opioid Testing in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 11 - Latin America Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Point-of-Care Opioid Testing in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Point-of-Care Opioid Testing in the Latin America region.
Chapter 12 - Europe Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Point-of-Care Opioid Testing in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Point-of-Care Opioid Testing in the regional market.
Chapter 13 - East Asia Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Point-of-Care Opioid Testing in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Point-of-Care Opioid Testing in the regional market.
Chapter 14 - South Asia Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Point-of-Care Opioid Testing in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Point-of-Care Opioid Testing in the regional market.
Chapter 15 - Middle East and Africa Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Point-of-Care Opioid Testing in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Point-of-Care Opioid Testing in the regional market.
Chapter 16 - Key Countries Point-of-Care Opioid Testing Analysis 2018-2022 and Forecast 2023-2033
This chapter offers insights into how the Point-of-Care Opioid Testing is expected to grow in major countries globally.
Chapter 17 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 18 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Product portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Avon Healthcare, Triveni Traders & Diagnostic Private Limited, AdvaCare Pharma USA, BTNX Inc., Phamatech, ADC, Worldwide Medical Corporation, Accu-Stat Diagnostics, Inc, ACON Laboratories, Inc., Alere, Innovacon, Inc., Amedica Biotech, Inc, Branan Medical Corporation, Biosite Inc, UCP Biosciences, Inc, TransMed Company, Vitrosens Biotechnology, Abbot, clarity diagnostics, Alcotec Company Limited
Chapter 19 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Point-of-Care Opioid Testing report.
Chapter 20 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Point-of-Care Opioid Testing.